Salient is an excellent design with a fresh approach for the ever-changing Web. Integrated with Gantry 5, it is infinitely customizable, incredibly powerful, and remarkably simple.


Prof. Dr. R.T. Grundmann

Aus World J Gastrointest Surg 2011; 3: 183-196


It is the objective of this article to give an overview on surgical treatment of patients with colorectal liver metastases (CLM) on the basis of a workflow that has been elaborated recently by an expert group [1]. The present update will focus on hepatic resection only as the procedure of choice for curative treatment of CLM. Hepatectomy allows 10-year survival rates of 16% [2] to 23 % [3]. The efficacy of ablative procedures such as radiofrequency ablation (RFA) will not be considered since the results of a panel of the American Society of Clinical Oncology (ASCO) demonstrate a compelling need for more research to determine the efficacy and utility of RFA to increase local recurrence-free, disease-free, and overall survival for patients with CLM [4].
Lesen Sie den ganzen Artikel (PDF-Download):
Current state of surgical treatment of liver metastases from colorectal cancer